Walgreen Co., now a subsidiary of Walgreen Boots Alliance, Inc., has announced it will sell a majority interest in Walgreen Infusion Services (WIS) to a private equity firm for an undisclosed sum. WIS has alternate treatment sites in 40 states and the ability to serve 90 percent of the US population. Madison Dearborn Partners (MDP), a Chicago-based private equity firm, has agreed to the purchase that will result in WIS becoming a new independent, privately held company.
Featured News
Supreme Court Lets CREXi Antitrust Case Against CoStar Move Forward
Mar 23, 2026 by
CPI
Oregon Just Passed the Country’s Toughest Chatbot Law. Your Company May Already Be Breaking It.
Mar 23, 2026 by
CPI
Newsmax, DirecTV Join Challenge to FCC’s Nexstar-Tegna Decision
Mar 23, 2026 by
CPI
House Committee Readies Hearing on Tokenized Securities Trading Rules
Mar 23, 2026 by
CPI
Vinson & Elkins Launches Brussels Office With Hire of Hogan Lovells Antitrust Partner
Mar 23, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Data-Driven Competition
Mar 19, 2026 by
CPI
Data-Driven Competition: Implications For Enforcement and Merger Control
Mar 19, 2026 by
Alexandre de Corniere & Greg Taylor
From Tipping to Trustees: Why Data-Driven Markets Require Institutional Design, Not Optimization
Mar 19, 2026 by
Jens Prüfer & Paul de Bijl
Data Barriers to Entry: What We’ve Learned About Spotting Them and What We Still Don’t Know About Solutions
Mar 19, 2026 by
Bruno Carballa-Smichowski
When the Perfect Is the Enemy of the Good: Price Discrimination, Affordability, Precarity and Market Dynamism
Mar 19, 2026 by
Dan Ciuriak